市場調查報告書

藥物局部給藥設備的全球市場:各類型、各給藥途徑、各利用設施、各地區的市場規模,趨勢分析,競爭模式,展望:2020年∼2027年

Global Topical Dispenser Market Size, By Type (Semisolids, Liquids, Solids, Transdermal Products), Route, Facility of Use, By Region, Trend Analysis, Market Competition Scenario & Outlook, 2020-2027

出版商 Blueweave Consulting & Research Private Limited 商品編碼 951547
出版日期 內容資訊 英文 177 Pages
商品交期: 最快1-2個工作天內
價格
藥物局部給藥設備的全球市場:各類型、各給藥途徑、各利用設施、各地區的市場規模,趨勢分析,競爭模式,展望:2020年∼2027年 Global Topical Dispenser Market Size, By Type (Semisolids, Liquids, Solids, Transdermal Products), Route, Facility of Use, By Region, Trend Analysis, Market Competition Scenario & Outlook, 2020-2027
出版日期: 2020年07月01日內容資訊: 英文 177 Pages
簡介

全球藥物局部給藥設備市場,預計從2019年的4,180億美元到2027年擴大到6,318億3,000萬美元,從2020年到2027年的年複合成長率預計為5.30%。局部給藥設備,是為了施給皮膚保護劑,軟膏,凝膠,乳膏,消毒劑等所使用的設備,隨著外用製劑的引進擴大而需求劇增。市場擴大的原動力,是預防感染疾病原因的細菌,非接觸藥物給藥的必要性高漲,藥物給藥的正確性等要素。

本報告提供全球藥物局部給藥設備市場調查,產業考察,市場概要,各地區的分析,主要企業的簡介等資訊。

目錄

第1章 調查架構

第2章 調查手法

第3章 摘要整理

第4章 產業的考察

  • 產業的價值鏈分析
  • DROC分析
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 課題
  • 技術形勢/最新趨勢
  • 法律規範
  • 各公司的市場佔有率分析
  • 波特的五力分析
  • COVID 19的影響

第5章 全球市場概要

  • 市場規模與預測:2016∼2026年
  • 市場佔有率與預測
    • 各產品類型
      • 半固態製劑
      • 液體製劑
      • 經皮吸收製劑
    • 各給藥途徑
      • 經皮
      • 經眼
      • 經直腸
      • 經陰道
      • 經鼻子
    • 各利用設施
      • 居家醫療
      • 醫院,診療所
      • 燙傷治療中心
      • 其他(學術研究機關,診斷中心)
    • 各地區
      • 北美
      • 歐洲
      • 亞太地區
      • 南美
      • 中東、非洲

第6章 北美市場

  • 市場規模與預測:2016∼2026年
  • 市場佔有率與預測
    • 各產品類型
    • 各給藥途徑
    • 各利用設施
    • 各國
      • 美國
      • 加拿大

第7章 歐洲市場

  • 市場規模與預測:2016∼2026年
  • 市場佔有率與預測
    • 各產品類型
    • 各給藥途徑
    • 各利用設施
    • 各國
      • 德國
      • 英國
      • 法國
      • 義大利
      • 西班牙
      • 其他

第8章 亞太地區市場

  • 市場規模與預測:2016∼2026年
  • 市場佔有率與預測
    • 各產品類型
    • 各給藥途徑
    • 各利用設施
    • 各國
      • 印度
      • 中國
      • 日本
      • 韓國
      • 其他

第9章 南美市場

  • 市場規模與預測:2016∼2026年
  • 市場佔有率與預測
    • 各產品類型
    • 各給藥途徑
    • 各利用設施
    • 各國
      • 巴西
      • 墨西哥
      • 其他

第10章 中東、非洲市場

  • 市場規模與預測:2016∼2026年
  • 市場佔有率與預測
    • 各產品類型
    • 各給藥途徑
    • 各利用設施
    • 各國
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 南非
      • 其他

第11章 企業簡介 (公司概要,財務矩陣,主要產品情勢,主要人物,主要的競爭企業,聯絡原住所,策略性展望)*

  • Johnson & Johnson
  • Nestle SA
  • Novartis AG
  • GlaxoSmithKline
  • Bausch Health Companies
  • Merck & Co (US), Bayer AG
  • Hisamitsu Pharmaceutical
  • Glenmark Pharmaceuticals
  • Cipla Ltd
  • Crescita Therapeutics Inc.
  • Mylan
  • Other Prominent Players
目錄
Product Code: BWC20095

The Global Topical Dispenser Market appraised at USD 418 billion in 2019 and is anticipated to reach USD 631.83 billion by 2027, at a CAGR of 5.30 % during the projection period

Topical applicators are used to administer peels and skin protectants, ointments, gels, creams, masks, disinfectants, and drugs. As more topical medications are being prescribed and introduced, the request for topical applicators is estimated to surge. Metered topical applicators ensure the precise quantity of drug/balm/cream/other medication for application on the body surface. The thematic device is user-friendly and dispenses the specified amount of medication with just one click. Topical applicators are reliable as they deliver automatic and consistent doses, assuring the same viscosity and no user-variability. They offer accuracy during the mixing and filling of the product and negate the chances of excess medication.

The primary reason for propelling the development of topical applicators is the growing need for medicine's contactless administration, assuring no transmission of bacteria carrying the infection. Besides, precision in dispensing medicine is another significant benefit and reason driving the global topical applicators market during the prediction period. High demand for topical applicators is being witnessed from the skincare sector. Topical applicators are widely used in dermal therapies and particularly for psoriasis. A large number of dermal medicinal applications are topical and require topical applicators for safe, secure, and precise administration. The therapeutic industry development in countries like China and India is predicted to push the topical applicators market during the prediction period.

Semi-solid formulations segment plays a significant role in the Topical Dispenser Market

Based on the product, the market is divided into semi-solid formulations (creams, pastes, gels, ointments, and lotions), liquid formulations (solutions and suspensions), solid formulations (suppositories and powders) and transdermal products (transdermal patches and transdermal semi-solids). The semi-solid formulations section captured the significant share of the market in 2019. The semi-solid arrangements offer advantages of faster drug release and better acceptability of topical gels by the patient. Extensive use of topical pastes to avoid skin irritation, infectiousness, and the possibility of quick removal of creams for curing various ailments related to different skin types is the dominant element stimulating this market's growth.

Homecare Settings dominates as a facility of use

Homecare settings accounted for the significant share of the market in 2018. Home care settings eliminate the need for patients to travel to healthcare facilities, thus saving time and money. Owing to convenience and affordability, a growing number of patients are opting for home-based cures. These factors reassure the growth of this market segment.

Drivers

Increasing prevalence of psoriasis and a rising aging population with skin diseases

Psoriasis is a long-lasting, sore, and non-communicable disease. It is most common in the geriatric population with age group 50 - 69. As per the National Psoriasis Foundation Report 2018, around 125 million people are under the distress of psoriasis worldwide. It has amplified the demand for topical dispensers in the industry. Skin diseases are the significant problems accounting for 1.79% of the global burden of diseases in DALYs of 306 diseases and injuries. As per the WHO, approximately 900 million people worldwide were suffering from skin ailments in 2018. This scenario is eventually growing the request for the topical dispenser, thereby fueling the market's development.

Easy use of Topical applicators

The precise and easy administration of medication with the topical applicators is the primary factor leading the global topical applicators market during the forthcoming period. Growing demand is being witnessed from the skincare sector, for different therapies and treatments, particularly for psoriasis. A large number of medications concerning skin are topical and need topical applicators for safe use. Metered topical applicators safeguard the application of the right quantity of ointment on the body external. They are dependable devices for the automated and accurate dose, reducing variability, and delivering uniform viscosity.

North America projected to witness significant growth in the market during the forecast period

North America dominated the market in 2018 and is expected to observe the highest CAGR during the prediction period. The prevalence of skin diseases, rising approvals and launches of innovative topical formulations in the region, and growing funding for topical drugs' development are some of the key elements driving this regional segment's growth. Emerging pharmaceutical industry in countries like China and India is expected to propel the topical applicators market during the forecast period. Europe is more evolved as topical applicators market compared to other regions such as Asia and MEA. The GCC countries and North Africa are anticipated to witness a medium to high growth in the topical applicators market during this period.

Global Topical Dispenser Market: Competitive Landscape

Companies such as Johnson & Johnson (US), Nestle SA (Switzerland), Novartis AG (Switzerland), GlaxoSmithKline (UK), Bausch Health Companies (Canada), Merck & Co (US), Bayer AG (Germany), Hisamitsu Pharmaceutical (Japan), Glenmark Pharmaceuticals (India), Cipla Ltd (India), Crescita Therapeutics Inc. (Canada), and Mylan (US) and others are prominent players in this market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Research Methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary & Secondary Sources
  • 2.2. Quantitative Research
    • 2.2.1. Primary & Secondary Sources
  • 2.3. Market Breakdown & Data Triangulation
    • 2.3.1. Secondary Research
    • 2.3.2. Primary Research
  • 2.4. Breakdown of Primary research respondent, By Region
  • 2.5. Assumption & Limitation

3. Executive Summary

4. Global Topical Dispenser market Industry Insights

  • 4.1. Industry Value Chain Analysis
  • 4.2. DROC Analysis
    • 4.2.1. Growth Drivers
    • 4.2.2. Restraint
    • 4.2.3. Opportunities
    • 4.2.4. Challenges
  • 4.3. Technological Landscape/Recent Development
  • 4.4. Regulatory Framework
  • 4.5. Company Market Share Analysis, 2019
  • 4.6. Porter's Five Forces Analysis
    • 4.6.1. Bargaining Power of Suppliers
    • 4.6.2. Bargaining Power of Buyers
    • 4.6.3. Threat of New Entrants
    • 4.6.4. Threat of Substitutes
    • 4.6.5. Intensity of Rivalry
  • 4.7. Impact of COVID 19

5. Global Topical Dispenser market Overview

  • 5.1. Market Size & Forecast by Value, 2016-2026
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product market Type
      • 5.2.1.1. Semi-solid Formulations
      • 5.2.1.1.1. Creams
      • 5.2.1.1.2. Ointments
      • 5.2.1.1.3. Lotions
      • 5.2.1.1.4. Gels
      • 5.2.1.1.5. Pastes
      • 5.2.1.2. Liquid Formulations
      • 5.2.1.2.1. Suspensions
      • 5.2.1.2.2. Solutions
      • 5.2.1.2.3. Solid Formulations
      • 5.2.1.2.4. Powders
      • 5.2.1.2.5. Suppositories
      • 5.2.1.3. Transdermal Products
      • 5.2.1.3.1. Transdermal Patches
      • 5.2.1.3.2. Transdermal Semi-solids
    • 5.2.2. By Route of Administration
      • 5.2.2.1. Dermal Drug Delivery
      • 5.2.2.2. Ophthalmic Drug Delivery
      • 5.2.2.3. Rectal Drug Delivery
      • 5.2.2.4. Vaginal Drug Delivery
      • 5.2.2.5. Nasal Drug Delivery
    • 5.2.3. By Facility of Use
      • 5.2.3.1. Homecare Settings
      • 5.2.3.2. Hospitals & Clinics
      • 5.2.3.3. Burn Centers
      • 5.2.3.4. Other Facilities (academic & research institutes and diagnostic centers)
    • 5.2.4. By Region
      • 5.2.4.1. North America
      • 5.2.4.2. Europe
      • 5.2.4.3. Asia Pacific
      • 5.2.4.4. Latin America
      • 5.2.4.5. Middle East & Africa

6. North America Topical Dispenser Market

  • 6.1. Market Size & Forecast by Value, 2016-2026
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Route of Administration
    • 6.2.3. By Facility of use
    • 6.2.4. By Country
      • 6.2.4.1. United States
      • 6.2.4.2. Canada

7. Europe Topical Dispenser market

  • 7.1. Market Size & Forecast by Value, 2016-2026
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Route of Administration
    • 7.2.3. By Facility of use
    • 7.2.4. By Country
      • 7.2.4.1. Germany
      • 7.2.4.2. United Kingdom
      • 7.2.4.3. France
      • 7.2.4.4. Italy
      • 7.2.4.5. Spain
      • 7.2.4.6. Rest of Europe

8. Asia Pacific Topical Dispenser Market

  • 8.1. Market Size & Forecast by Value, 2016-2026
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Route of Administration
    • 8.2.3. By Facility of use
    • 8.2.4. By Country
      • 8.2.4.1. India
      • 8.2.4.2. China
      • 8.2.4.3. Japan
      • 8.2.4.4. South Korea
      • 8.2.4.5. Rest of Asia Pacific

9. Latin America Topical Dispenser Market

  • 9.1. Market Size & Forecast by Value, 2016-2026
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Route of Administration
    • 9.2.3. By Facility of use
    • 9.2.4. By Country
      • 9.2.4.1. Brazil
      • 9.2.4.2. Mexico
      • 9.2.4.3. Rest of Latin America

10. Middle East & Africa Topical Dispenser Market

  • 10.1. Market Size & Forecast by Value, 2016-2026
    • 10.1.1. By Value (USD Million)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Route of Administration
    • 10.2.3. By Facility of use
    • 10.2.4. By Country
      • 10.2.4.1. Saudi Arabia
      • 10.2.4.2. UAE
      • 10.2.4.3. South Africa
      • 10.2.4.4. Rest of Middle East & Africa

11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

  • 11.1. Johnson & Johnson
  • 11.2. Nestle SA
  • 11.3. Novartis AG
  • 11.4. GlaxoSmithKline
  • 11.5. Bausch Health Companies
  • 11.6. Merck & Co (US), Bayer AG
  • 11.7. Hisamitsu Pharmaceutical
  • 11.8. Glenmark Pharmaceuticals
  • 11.9. Cipla Ltd
  • 11.10. Crescita Therapeutics Inc.
  • 11.11. Mylan
  • 11.12. Other Prominent Players